These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 10448991

  • 1. Fusidic acid as a potential antistaphylococcal agent.
    Nicholson J, Chew T, Smith S.
    N Z Med J; 1999 Jul 09; 112(1091):261-2. PubMed ID: 10448991
    [No Abstract] [Full Text] [Related]

  • 2. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP, Grayson ML.
    Clin Infect Dis; 2006 Feb 01; 42(3):394-400. PubMed ID: 16392088
    [Abstract] [Full Text] [Related]

  • 3. Clinical implications of methicillin-resistance in Staphylococcus aureus.
    Harris DM.
    Guys Hosp Rep; 1970 Feb 01; 119(2):145-54. PubMed ID: 5202526
    [No Abstract] [Full Text] [Related]

  • 4. In-vitro activity of fusidic acid against methicillin-resistant Staphylococcus aureus.
    Erdenizmenli M, Yapar N, Sengönül A, Yüce A, Cakir N, Yulug N.
    J Chemother; 2004 Jun 01; 16(3):310-1. PubMed ID: 15330332
    [No Abstract] [Full Text] [Related]

  • 5. A fatal infection caused by methicillin-resistant Staphylococcus aureus acquiring resistance to gentamicin and fusidic acid during therapy.
    Amirak ID, Li AK, Williams RJ, Noone P.
    J Infect; 1981 Mar 01; 3(1):50-8. PubMed ID: 6926536
    [No Abstract] [Full Text] [Related]

  • 6. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
    Reynaud AE, Espaze EP, Coste-Burel M, Richet H.
    Pathol Biol (Paris); 1992 May 01; 40(5):466-70. PubMed ID: 1495828
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA, Mascini EM, Blok HE, Sanders CJ.
    Ned Tijdschr Geneeskd; 2002 Nov 02; 146(44):2100-1. PubMed ID: 12448968
    [Abstract] [Full Text] [Related]

  • 12. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO, Bayar B, Kurt O, Cokça F.
    Mikrobiyol Bul; 2002 Apr 02; 36(2):141-5. PubMed ID: 12652865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efforts to support the development of fusidic acid in the United States.
    Fernandes P, Pereira D.
    Clin Infect Dis; 2011 Jun 02; 52 Suppl 7():S542-6. PubMed ID: 21546632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.